1996
DOI: 10.1055/s-0038-1650608
|View full text |Cite
|
Sign up to set email alerts
|

Transport Processes in Fibrinolysis and Fibrinolytic Therapy

Abstract: Crucial. Each week, doctors read The New E ng la nd jo u rn a l of M edicine because they know it is the central information source for crucial medical studies, and affects their ability to provide the best care to their patients. Global. In 1995,34% of all articles published were written by researchers outside the United States. The NEJM's editorial board has 8 members from countries outside the United States who help to give The NEJM a global perspective. The NEJM is the largest paid-circulation medical jour… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
64
0

Year Published

1999
1999
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 83 publications
(66 citation statements)
references
References 100 publications
(139 reference statements)
0
64
0
Order By: Relevance
“…Transport of plasminogen activator into a thrombus is rate-limiting, because flow is obstructed. 16 Drug access by diffusion is very slow, but previous studies in a static system have shown that US increases clot uptake of activator and results in greater depth of penetration. 17 US also increases pressure-mediated perfusion through a fibrin matrix, 18 and both of these effects would increase drug delivery and accelerate fibrinolysis.…”
Section: Discussionmentioning
confidence: 99%
“…Transport of plasminogen activator into a thrombus is rate-limiting, because flow is obstructed. 16 Drug access by diffusion is very slow, but previous studies in a static system have shown that US increases clot uptake of activator and results in greater depth of penetration. 17 US also increases pressure-mediated perfusion through a fibrin matrix, 18 and both of these effects would increase drug delivery and accelerate fibrinolysis.…”
Section: Discussionmentioning
confidence: 99%
“…Clot permeability using multiphase CTA/value of CTA in evaluating the clot Thrombolysis in any vascular bed depends on the ability of blood and thrombolytic agents to permeate clot [34,35] Permeation of blood flow through the clot or part of it is defined as residual blood flow; this allows the IVT to reach beyond the proximal part of the clot, leading to higher chance of recanalization. Residual blood flow can be observed in CTA source images by clearly visibly increased contrast attenuation through the clot compared with surrounding brain parenchyma [26].…”
Section: Assessment Of Clotmentioning
confidence: 99%
“…49,50 Experimental and clinical evidence suggests that systemic administration of thrombolytic agents, which is effective in small arteries such as the coronaries, is ineffective for treatment of DVT, likely because of inefficient diffusion of these agents into the matrix of large venous thrombi under conditions of low flow. [51][52][53] Furthermore, systemic thrombolysis for DVT is associated with a greater risk of bleeding compared with that observed with anticoagulation alone. 47,48,54 These observations prompted studies of catheter-directed, local infusion of thrombolytic agents to minimize bleeding and enhance clot dissolution.…”
Section: Pharmacological Thrombolysismentioning
confidence: 99%